(Q36210919)

12 August 2017

1 reference

title

Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs (English)

1 reference

12 August 2017

Robson A S Santos

1

1 reference

12 August 2017

Anderson J Ferreira

2

1 reference

12 August 2017

Sérgio V B Pinheiro

3

1 reference

12 August 2017

Walkyria O Sampaio

4

1 reference

12 August 2017

Rhian Touyz

5

1 reference

12 August 2017

Maria José Campagnole-Santos

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

8

1 reference

12 August 2017

page(s)

1019-1031

1 reference

Angiotensin II receptor antagonists

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Drugs targeting the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

The renin-angiotensin and the kallikrein-kinin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

The renin-angiotensin system: peptides and enzymes beyond angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

ACE2, a new regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

The role of ACE2 in cardiovascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

ACE2 gene expression is up-regulated in the human failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Vasodilator effect of angiotensin-(1-7) in mature and sponge-induced neovasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

ACE inhibitor potentiation of bradykinin-induced venoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Baroreflex improvement in shr after ace inhibition involves angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

[7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Human astrocytes contain two distinct angiotensin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Interactions between angiotensin-(1-7), kinins, and angiotensin II in kidney and blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

Losartan increases bradykinin levels in hypertensive humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.8.1019

10.1517/13543784.14.8.1019

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference